首页 > 最新文献

Epilepsy Research最新文献

英文 中文
Challenges to epilepsy surgery referral in Mexico: Results from a nationwide survey of primary care physicians and specialists. 墨西哥癫痫手术转诊面临的挑战:一项针对初级保健医生和专家的全国性调查结果。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-02-06 DOI: 10.1016/j.eplepsyres.2026.107750
Diego Pichardo-Rojas, Jorge Castro-Vega, María Fernanda Castelo-Pablos, Jonathan Ulises Macias-López, Karen Janely Camarena-Rubio, Irene Gómez-Oropeza, Valeria Isabel Bravo-Osorno, Manuel Alejandro Del Río Quiñones, Juan Carlos Reséndiz Aparicio, Mauricio Medina, Elma Paredes-Aragón, Sonia Iliana Mejía-Pérez, Laura E Hernández-Vanegas

Background: Epilepsy surgery is the most effective treatment for patients with drug-resistant epilepsy (DRE), yet remains critically underutilized. Physician perceptions and knowledge gaps are amongst the most consistently reported barriers to timely referral, with limited reports in low- and middle-income countries (LMICs). This study aimed to assess knowledge and perceptions regarding DRE and epilepsy surgery among Mexican physicians.

Methods: A 24-item survey was distributed nationally between August and November 2024. Eligible respondents were practicing general practitioners (GPs), neurologists, or neurosurgeons in Mexico. Items evaluated demographics, clinical experience with epilepsy, perceptions of surgery, and knowledge of International League Against Epilepsy (ILAE) recommendations. Intergroup comparisons were performed using chi-square and logistic regression analyses.

Results: Responses were obtained from 211 physicians across 27 states, including 140 GPs (66.4 %), 40 neurologists (19.0 %), and 31 neurosurgeons (14.6 %). Only 72 physicians (34.1 %) correctly identified the ILAE definition of DRE, including 55 % of neurologists (significant differences between groups p = 0.008). While 180 participants (85.3 %) recognized epilepsy surgery as a treatment option, only 107 (50.7 %) agreed that all DRE patients should be referred for surgical evaluation. Awareness of existing referral centers was low (n = 60, 28.4 %). Most respondents recognized EEG (n = 184, 87.2 %), and MRI (n = 125/211 59.2 %) as essential for initial evaluation. Notably, 82 physicians (38.9 %) perceived epilepsy surgery as a high-risk, last-resort option. Overall, neurologists had the highest knowledge of epilepsy.

Conclusion: Mexican physicians had significant knowledge gaps and referral barriers to epilepsy surgery in Mexico, including limited familiarity with DRE criteria, limited understanding of surgical outcomes, and low awareness of existing referral pathways. Addressing these gaps through targeted medical education and improved visibility of epilepsy care infrastructure is essential to improve outcomes for DRE patients in Mexico and other LMICs.

背景:癫痫手术是治疗耐药癫痫(drug-resistant Epilepsy, DRE)最有效的方法,但仍未得到充分利用。医生的认知和知识差距是最一致报告的及时转诊障碍之一,低收入和中等收入国家(LMICs)的报告有限。本研究旨在评估墨西哥医生关于DRE和癫痫手术的知识和认知。方法:于2024年8月至11月在全国范围内进行24项调查。符合条件的调查对象是墨西哥的全科医生、神经科医生或神经外科医生。项目评估了人口统计学、癫痫临床经验、对手术的认知以及对国际抗癫痫联盟(ILAE)建议的了解。组间比较采用卡方和逻辑回归分析。结果:获得了来自27个州211名医生的回复,其中包括140名全科医生(66.4 %),40名神经科医生(19.0 %)和31名神经外科医生(14.6 %)。只有72名医生(34.1% %)正确识别了DRE的ILAE定义,其中神经科医生为55 %(组间差异显著p = 0.008)。180名参与者(85.3 %)承认癫痫手术是一种治疗选择,只有107名参与者(50.7 %)同意所有DRE患者都应该进行手术评估。对现有转诊中心的知晓度较低(n = 60,28.4 %)。大多数受访者认为脑电图(n = 184,87.2 %)和MRI (n = 125/211 59.2 %)是初步评估的必要条件。值得注意的是,82名医生(38.9 %)认为癫痫手术是高风险的最后选择。总的来说,神经科医生对癫痫的了解程度最高。结论:墨西哥医生在墨西哥癫痫手术方面存在明显的知识差距和转诊障碍,包括对DRE标准的熟悉程度有限,对手术结果的了解有限,对现有转诊途径的认识较低。通过有针对性的医学教育和提高癫痫治疗基础设施的可见度来解决这些差距,对于改善墨西哥和其他低收入和中等收入国家DRE患者的预后至关重要。
{"title":"Challenges to epilepsy surgery referral in Mexico: Results from a nationwide survey of primary care physicians and specialists.","authors":"Diego Pichardo-Rojas, Jorge Castro-Vega, María Fernanda Castelo-Pablos, Jonathan Ulises Macias-López, Karen Janely Camarena-Rubio, Irene Gómez-Oropeza, Valeria Isabel Bravo-Osorno, Manuel Alejandro Del Río Quiñones, Juan Carlos Reséndiz Aparicio, Mauricio Medina, Elma Paredes-Aragón, Sonia Iliana Mejía-Pérez, Laura E Hernández-Vanegas","doi":"10.1016/j.eplepsyres.2026.107750","DOIUrl":"https://doi.org/10.1016/j.eplepsyres.2026.107750","url":null,"abstract":"<p><strong>Background: </strong>Epilepsy surgery is the most effective treatment for patients with drug-resistant epilepsy (DRE), yet remains critically underutilized. Physician perceptions and knowledge gaps are amongst the most consistently reported barriers to timely referral, with limited reports in low- and middle-income countries (LMICs). This study aimed to assess knowledge and perceptions regarding DRE and epilepsy surgery among Mexican physicians.</p><p><strong>Methods: </strong>A 24-item survey was distributed nationally between August and November 2024. Eligible respondents were practicing general practitioners (GPs), neurologists, or neurosurgeons in Mexico. Items evaluated demographics, clinical experience with epilepsy, perceptions of surgery, and knowledge of International League Against Epilepsy (ILAE) recommendations. Intergroup comparisons were performed using chi-square and logistic regression analyses.</p><p><strong>Results: </strong>Responses were obtained from 211 physicians across 27 states, including 140 GPs (66.4 %), 40 neurologists (19.0 %), and 31 neurosurgeons (14.6 %). Only 72 physicians (34.1 %) correctly identified the ILAE definition of DRE, including 55 % of neurologists (significant differences between groups p = 0.008). While 180 participants (85.3 %) recognized epilepsy surgery as a treatment option, only 107 (50.7 %) agreed that all DRE patients should be referred for surgical evaluation. Awareness of existing referral centers was low (n = 60, 28.4 %). Most respondents recognized EEG (n = 184, 87.2 %), and MRI (n = 125/211 59.2 %) as essential for initial evaluation. Notably, 82 physicians (38.9 %) perceived epilepsy surgery as a high-risk, last-resort option. Overall, neurologists had the highest knowledge of epilepsy.</p><p><strong>Conclusion: </strong>Mexican physicians had significant knowledge gaps and referral barriers to epilepsy surgery in Mexico, including limited familiarity with DRE criteria, limited understanding of surgical outcomes, and low awareness of existing referral pathways. Addressing these gaps through targeted medical education and improved visibility of epilepsy care infrastructure is essential to improve outcomes for DRE patients in Mexico and other LMICs.</p>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"107750"},"PeriodicalIF":2.0,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation-mediated function enhancement of KNa channels promotes network hyperactivity in the peripheral cortex following TBI. 炎症介导的KNa通道功能增强促进TBI后外周皮层的网络亢进。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-02-04 DOI: 10.1016/j.eplepsyres.2026.107751
Lei Sun, Ru Liu, Xiong Han, Na Wang, Ting Zhao, Yanan Chen, Jianping Wu, Junfan Chen, Qun Wang

Background: Post-traumatic epilepsy (PTE) is a common complication of traumatic brain injury (TBI). Studies have indicated that functional abnormalities of the sodium-activated potassium (KNa) channels are closely related to infantile "refractory epilepsy". However, whether and how the KNa channels are involved in the occurrence of PTE remains unknown.

Methods: We used adult male C57BL/6 J mice to establish a controlled cortical impact (CCI) mice model with different severity levels. We implanted intracranial electrodes 7 days after injury to observe the spontaneous seizures in the moderately injured mice.vEEG was continuously recorded for 7 days (24 h/day). Then, a multi - electrode array (MEA) was performed 14 days after TBI to evaluate the network activity in the peripheral cortex of TBI lesions.Seven days after injury, we detected the expression of KNa channels around the injury site and the activation of glial cells through immunofluorescence staining. Finally, primary neuron cultures were used to verify whether or not the inflammatory factor upregulated KNa channels and affected neuronal excitability by activating the NF-κB pathway.

Results: Through continuous vEEG monitoring, we observed abnormal electrographic discharges in the moderate TBI group (9 %, 2/22). MEA recording confirmed hyperactive network around the lesion, supporting that peripheral cortex may be the potential epileptogenic focus. Our findings revealed that expression of KNa channels was elevated in neuronal membranes in the peripheral cortex. Reactive astrocytes and activated microglia were observed in the injured ipsilateral cortex of the moderate and severe TBI mice. In primary neurons, we found that KNa currents were markedly increased after TNF-α stimulation. When the NF-κB signaling pathway was inhibited by SN50, the KNa currents were correspondingly decreased.

Conclusions: Our results suggest that network hyperactivity in the perilesional neocortex may be the origin of abnormal epileptiform discharge. Activation of glial cells around the lesion releases inflammatory factors that initiate the NF-κB signaling pathway and modulate the KNa channels, which may be a potential mechanism for the occurrence of PTE. This research had important implications for clarifying the origin of epileptic foci of TBI and identifying immune-based biomarkers to improve the prognosis of PTE.

背景:创伤后癫痫(PTE)是创伤性脑损伤(TBI)的常见并发症。研究表明,钠活化钾(KNa)通道的功能异常与婴幼儿“难治性癫痫”密切相关。然而,KNa通道是否以及如何参与PTE的发生仍然未知。方法:采用成年雄性C57BL/6 J小鼠建立不同严重程度的控制性皮质冲击(CCI)小鼠模型。我们在损伤后7天植入颅电极,观察中度损伤小鼠的自发性癫痫发作情况。连续记录vEEG 7 d(24 h/day)。然后,在TBI后14天进行多电极阵列(MEA)来评估TBI病变周围皮层的网络活动。损伤7天后,我们通过免疫荧光染色检测损伤部位周围KNa通道的表达和神经胶质细胞的活化。最后,用原代神经元培养来验证炎症因子是否通过激活NF-κB通路上调KNa通道并影响神经元的兴奋性。结果:通过连续vEEG监测,我们观察到中度TBI组脑电放电异常(9 %,2/22)。MEA记录证实病变周围有过度活跃的网络,支持外周皮层可能是潜在的致痫灶。我们的研究结果显示外周皮层神经元膜中KNa通道的表达升高。中、重度脑外伤小鼠同侧皮质出现星形胶质细胞反应和小胶质细胞活化。在原代神经元中,我们发现TNF-α刺激后KNa电流明显增加。当SN50抑制NF-κB信号通路时,KNa电流相应降低。结论:我们的研究结果提示病灶周围新皮层的网络亢进可能是异常癫痫样放电的起源。病变周围的神经胶质细胞激活释放炎症因子,启动NF-κB信号通路,调节KNa通道,这可能是PTE发生的潜在机制,本研究对阐明TBI癫痫灶的起源,识别基于免疫的生物标志物,改善PTE预后具有重要意义。
{"title":"Inflammation-mediated function enhancement of K<sub>Na</sub> channels promotes network hyperactivity in the peripheral cortex following TBI.","authors":"Lei Sun, Ru Liu, Xiong Han, Na Wang, Ting Zhao, Yanan Chen, Jianping Wu, Junfan Chen, Qun Wang","doi":"10.1016/j.eplepsyres.2026.107751","DOIUrl":"https://doi.org/10.1016/j.eplepsyres.2026.107751","url":null,"abstract":"<p><strong>Background: </strong>Post-traumatic epilepsy (PTE) is a common complication of traumatic brain injury (TBI). Studies have indicated that functional abnormalities of the sodium-activated potassium (K<sub>Na</sub>) channels are closely related to infantile \"refractory epilepsy\". However, whether and how the K<sub>Na</sub> channels are involved in the occurrence of PTE remains unknown.</p><p><strong>Methods: </strong>We used adult male C57BL/6 J mice to establish a controlled cortical impact (CCI) mice model with different severity levels. We implanted intracranial electrodes 7 days after injury to observe the spontaneous seizures in the moderately injured mice.vEEG was continuously recorded for 7 days (24 h/day). Then, a multi - electrode array (MEA) was performed 14 days after TBI to evaluate the network activity in the peripheral cortex of TBI lesions.Seven days after injury, we detected the expression of K<sub>Na</sub> channels around the injury site and the activation of glial cells through immunofluorescence staining. Finally, primary neuron cultures were used to verify whether or not the inflammatory factor upregulated K<sub>Na</sub> channels and affected neuronal excitability by activating the NF-κB pathway.</p><p><strong>Results: </strong>Through continuous vEEG monitoring, we observed abnormal electrographic discharges in the moderate TBI group (9 %, 2/22). MEA recording confirmed hyperactive network around the lesion, supporting that peripheral cortex may be the potential epileptogenic focus. Our findings revealed that expression of K<sub>Na</sub> channels was elevated in neuronal membranes in the peripheral cortex. Reactive astrocytes and activated microglia were observed in the injured ipsilateral cortex of the moderate and severe TBI mice. In primary neurons, we found that K<sub>Na</sub> currents were markedly increased after TNF-α stimulation. When the NF-κB signaling pathway was inhibited by SN50, the K<sub>Na</sub> currents were correspondingly decreased.</p><p><strong>Conclusions: </strong>Our results suggest that network hyperactivity in the perilesional neocortex may be the origin of abnormal epileptiform discharge. Activation of glial cells around the lesion releases inflammatory factors that initiate the NF-κB signaling pathway and modulate the K<sub>Na</sub> channels, which may be a potential mechanism for the occurrence of PTE. This research had important implications for clarifying the origin of epileptic foci of TBI and identifying immune-based biomarkers to improve the prognosis of PTE.</p>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"107751"},"PeriodicalIF":2.0,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146136995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examination of psychological resilience and self-esteem in adolescents having siblings with epilepsy. 兄弟姐妹患有癫痫的青少年的心理弹性和自尊的检查。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-02-04 DOI: 10.1016/j.eplepsyres.2026.107741
Buşra Kantarcı, Fatma Kurudi̇rek

Objective: This study aimed to examine the relationship between psychological resilience and self-esteem among healthy adolescents who have siblings diagnosed with epilepsy.

Methods: This descriptive and cross-sectional study was conducted between May and November 2024 at Muş State Hospital. The sample consisted of 126 healthy adolescents aged 12-18 years who had siblings diagnosed with epilepsy and were receiving follow-up care at the pediatric neurology outpatient clinic. Data were collected using a Personal Information Form, the Rosenberg Self-Esteem Scale (RSES), and the Child and Youth Resilience Measure (CYRM).

Results: The mean CYRM score was 41.32 ± 9.87, indicating moderate psychological resilience, and the mean RSES score was 2.11 ± 1.75, indicating moderate self-esteem. Psychological resilience scores were significantly higher among girls and adolescents from higher-income families, as well as those whose parents had higher educational levels and professional occupations. Self-esteem levels were higher among adolescents whose parents were university graduates or civil servants and lower among those from low-income families. Emotional responses during siblings' seizures were also associated with both outcomes; adolescents reporting compassion or sadness demonstrated higher psychological resilience and self-esteem than those reporting pity. A moderate negative correlation was found between CYRM and RSES scores, reflecting the inverse scoring structure of the RSES, in which lower scores indicate higher self-esteem.

Conclusion: Adolescents who have siblings with epilepsy exhibit moderate levels of psychological resilience and self-esteem compared with normative adolescent samples. Sociodemographic characteristics and emotional responses to seizures play an important role in shaping these outcomes, highlighting the need for psychosocial support strategies to strengthen resilience and self-esteem.

目的:探讨兄弟姐妹患有癫痫的健康青少年心理弹性与自尊的关系。方法:这项描述性和横断面研究于2024年5月至11月在穆乌伊州立医院进行。样本包括126名12-18岁的健康青少年,他们的兄弟姐妹被诊断患有癫痫,并在儿科神经病学门诊接受随访治疗。数据收集采用个人信息表,罗森博格自尊量表(RSES)和儿童和青少年弹性测量(CYRM)。结果:CYRM平均得分为41.32 ± 9.87,心理弹性中等;RSES平均得分为2.11 ± 1.75,自尊中等。来自高收入家庭的女孩和青少年的心理弹性得分明显更高,父母的教育水平和专业职业也更高。父母是大学毕业生或公务员的青少年的自尊水平较高,而来自低收入家庭的青少年的自尊水平较低。兄弟姐妹癫痫发作时的情绪反应也与这两种结果有关;报告同情或悲伤的青少年比报告怜悯的青少年表现出更高的心理弹性和自尊。CYRM与RSES得分呈中等负相关,反映了RSES的逆得分结构,得分越低表明自尊越高。结论:与正常青少年样本相比,兄弟姐妹患有癫痫的青少年表现出中等水平的心理弹性和自尊。社会人口学特征和对癫痫发作的情绪反应在形成这些结果方面发挥着重要作用,强调需要社会心理支持策略来加强恢复力和自尊。
{"title":"Examination of psychological resilience and self-esteem in adolescents having siblings with epilepsy.","authors":"Buşra Kantarcı, Fatma Kurudi̇rek","doi":"10.1016/j.eplepsyres.2026.107741","DOIUrl":"https://doi.org/10.1016/j.eplepsyres.2026.107741","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to examine the relationship between psychological resilience and self-esteem among healthy adolescents who have siblings diagnosed with epilepsy.</p><p><strong>Methods: </strong>This descriptive and cross-sectional study was conducted between May and November 2024 at Muş State Hospital. The sample consisted of 126 healthy adolescents aged 12-18 years who had siblings diagnosed with epilepsy and were receiving follow-up care at the pediatric neurology outpatient clinic. Data were collected using a Personal Information Form, the Rosenberg Self-Esteem Scale (RSES), and the Child and Youth Resilience Measure (CYRM).</p><p><strong>Results: </strong>The mean CYRM score was 41.32 ± 9.87, indicating moderate psychological resilience, and the mean RSES score was 2.11 ± 1.75, indicating moderate self-esteem. Psychological resilience scores were significantly higher among girls and adolescents from higher-income families, as well as those whose parents had higher educational levels and professional occupations. Self-esteem levels were higher among adolescents whose parents were university graduates or civil servants and lower among those from low-income families. Emotional responses during siblings' seizures were also associated with both outcomes; adolescents reporting compassion or sadness demonstrated higher psychological resilience and self-esteem than those reporting pity. A moderate negative correlation was found between CYRM and RSES scores, reflecting the inverse scoring structure of the RSES, in which lower scores indicate higher self-esteem.</p><p><strong>Conclusion: </strong>Adolescents who have siblings with epilepsy exhibit moderate levels of psychological resilience and self-esteem compared with normative adolescent samples. Sociodemographic characteristics and emotional responses to seizures play an important role in shaping these outcomes, highlighting the need for psychosocial support strategies to strengthen resilience and self-esteem.</p>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"107741"},"PeriodicalIF":2.0,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146124302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and hematologic predictors of early intensive care unit admission in seizure patients presenting to the emergency room. 癫痫患者进入急诊室的早期重症监护病房的临床和血液学预测因素
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-02-03 DOI: 10.1016/j.eplepsyres.2026.107752
Eun Seok Park, Hyo Min Shin, Sung-Woo Kim, Won-Joo Kim, Heewon Hwang

Objective: History of hypertension is a common comorbidity among patients with epilepsy, yet its role in acute seizure outcomes remains unclear. This study investigated whether history of hypertension and routine hematologic markers could predict intensive care unit (ICU) admission among patients with seizures presenting to the emergency room (ER).

Methods: Ninety patients with confirmed seizures were retrospectively analysed. Demographic characteristics, comorbidities, and laboratory findings were compared between patients admitted to the ICU and those who were not. Multivariate logistic regression analysis identified independent predictors of ICU admission. In addition, all 20 ICU-admitted cases during the study period were further examined to characterize their clinical patterns.

Results: Twenty patients (22.2 %) required direct ICU admission. History of hypertension was more frequent in the ICU group (45.0 % vs. 17.1 %, p = 0.009) and independently predicted ICU admission (OR 4.07, 95 % CI 1.05-15.80, p = 0.042). Elevated white blood cell counts (OR 1.27, 95 % CI 1.10-1.48, p = 0.002) and reduced red blood cell counts (OR 0.17, 95 % CI 0.05-0.59, p = 0.006) were also significant predictors.

Conclusion: History of hypertension, leukocytosis, and anemia may indicate a higher risk of clinical deterioration in patients with seizures. These routinely available measures could assist early triage and management decisions in the ER. Prospective studies are warranted to confirm their prognostic utility.

目的:高血压史是癫痫患者的常见合并症,但其在急性发作结局中的作用尚不清楚。本研究探讨高血压病史和常规血液学指标是否可以预测癫痫发作患者进入急诊室的重症监护病房(ICU)。方法:对90例确诊癫痫发作患者进行回顾性分析。比较了ICU和非ICU患者的人口学特征、合并症和实验室结果。多因素logistic回归分析确定了ICU住院的独立预测因素。此外,在研究期间对所有20例icu住院病例进行进一步检查,以确定其临床模式。结果:20例(22.2% %)需直接入住ICU。高血压病史在ICU组更为常见(45.0 % vs. 17.1 %,p = 0.009),并且独立预测ICU入院(OR 4.07, 95 % CI 1.05-15.80, p = 0.042)。白细胞计数升高(OR 1.27, 95 % CI 1.10-1.48, p = 0.002)和红细胞计数降低(OR 0.17, 95 % CI 0.05-0.59, p = 0.006)也是显著的预测因子。结论:高血压、白细胞增多和贫血病史可能提示癫痫发作患者临床恶化的高风险。这些常规措施可以帮助急诊室的早期分诊和管理决策。有必要进行前瞻性研究以证实其预后效用。
{"title":"Clinical and hematologic predictors of early intensive care unit admission in seizure patients presenting to the emergency room.","authors":"Eun Seok Park, Hyo Min Shin, Sung-Woo Kim, Won-Joo Kim, Heewon Hwang","doi":"10.1016/j.eplepsyres.2026.107752","DOIUrl":"https://doi.org/10.1016/j.eplepsyres.2026.107752","url":null,"abstract":"<p><strong>Objective: </strong>History of hypertension is a common comorbidity among patients with epilepsy, yet its role in acute seizure outcomes remains unclear. This study investigated whether history of hypertension and routine hematologic markers could predict intensive care unit (ICU) admission among patients with seizures presenting to the emergency room (ER).</p><p><strong>Methods: </strong>Ninety patients with confirmed seizures were retrospectively analysed. Demographic characteristics, comorbidities, and laboratory findings were compared between patients admitted to the ICU and those who were not. Multivariate logistic regression analysis identified independent predictors of ICU admission. In addition, all 20 ICU-admitted cases during the study period were further examined to characterize their clinical patterns.</p><p><strong>Results: </strong>Twenty patients (22.2 %) required direct ICU admission. History of hypertension was more frequent in the ICU group (45.0 % vs. 17.1 %, p = 0.009) and independently predicted ICU admission (OR 4.07, 95 % CI 1.05-15.80, p = 0.042). Elevated white blood cell counts (OR 1.27, 95 % CI 1.10-1.48, p = 0.002) and reduced red blood cell counts (OR 0.17, 95 % CI 0.05-0.59, p = 0.006) were also significant predictors.</p><p><strong>Conclusion: </strong>History of hypertension, leukocytosis, and anemia may indicate a higher risk of clinical deterioration in patients with seizures. These routinely available measures could assist early triage and management decisions in the ER. Prospective studies are warranted to confirm their prognostic utility.</p>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"107752"},"PeriodicalIF":2.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoimmune-associated epilepsy or acute symptomatic seizures? A case series of recurrent seizures in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) 自身免疫性癫痫还是急性症状性癫痫?髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)患者系列反复发作1例
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-01-28 DOI: 10.1016/j.eplepsyres.2026.107740
Alexander J Jonokuchi , Ilya Kister , Angie H. Kim , Claude Steriade
Acute symptomatic seizures are a well recognized symptom of myelin oligodendrocyte antibody-associated disease (MOGAD), but long-term seizure outcomes and risk of epilepsy are understudied. In a retrospective cohort of 135 consecutive patients meeting consensus criteria for MOGAD without a prior diagnosis of epilepsy or concurrent NMDA-R Ab positivity, 19 developed seizures after MOGAD onset (16 %). Of these 19 patients, 7 patients (37 % of those with seizures, and 5 % of the total cohort). experienced one or more seizure recurrence during MOGAD remission (i.e. outside of an acute attack). Five of the 7 patients with recurrent seizures remained on antiseizure medication (ASM) (four on monotherapy and one on two ASMs) at last follow-up (median duration of follow up: 92 months). We discuss phenotypes of recurrent seizures in patients with MOGAD in the context of the conceptual framework of acute symptomatic seizures versus autoimmune encephalitis associated epilepsy (AEAE).
急性症状性癫痫发作是髓鞘少突胶质细胞抗体相关疾病(MOGAD)的一个公认症状,但长期癫痫发作的结果和癫痫的风险尚未得到充分研究。在135例符合MOGAD共识标准的连续患者的回顾性队列中,没有先前的癫痫诊断或并发NMDA-R Ab阳性,19例在MOGAD发作后发生癫痫发作(16% %)。在这19名患者中,7名患者(占癫痫发作患者的37% %,占总队列的5% %)。在MOGAD缓解期间(即急性发作之外)经历一次或多次癫痫复发。7例复发性癫痫患者中有5例在最后随访时仍在服用抗癫痫药物(ASM)(4例单药治疗,1例双药治疗)(中位随访时间:92个月)。我们在急性症状性癫痫与自身免疫性脑炎相关癫痫(AEAE)的概念框架的背景下讨论MOGAD患者复发性癫痫发作的表型。
{"title":"Autoimmune-associated epilepsy or acute symptomatic seizures? A case series of recurrent seizures in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","authors":"Alexander J Jonokuchi ,&nbsp;Ilya Kister ,&nbsp;Angie H. Kim ,&nbsp;Claude Steriade","doi":"10.1016/j.eplepsyres.2026.107740","DOIUrl":"10.1016/j.eplepsyres.2026.107740","url":null,"abstract":"<div><div>Acute symptomatic seizures are a well recognized symptom of myelin oligodendrocyte antibody-associated disease (MOGAD), but long-term seizure outcomes and risk of epilepsy are understudied. In a retrospective cohort of 135 consecutive patients meeting consensus criteria for MOGAD without a prior diagnosis of epilepsy or concurrent NMDA-R Ab positivity, 19 developed seizures after MOGAD onset (16 %). Of these 19 patients, 7 patients (37 % of those with seizures, and 5 % of the total cohort). experienced one or more seizure recurrence during MOGAD remission (i.e. outside of an acute attack). Five of the 7 patients with recurrent seizures remained on antiseizure medication (ASM) (four on monotherapy and one on two ASMs) at last follow-up (median duration of follow up: 92 months). We discuss phenotypes of recurrent seizures in patients with MOGAD in the context of the conceptual framework of acute symptomatic seizures versus autoimmune encephalitis associated epilepsy (AEAE).</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"Article 107740"},"PeriodicalIF":2.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146075797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CHD2-related disorders: A conceptual disease model informed by caregiver experience. chd2相关疾病:由护理者经验告知的概念性疾病模型
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-01-28 DOI: 10.1016/j.eplepsyres.2026.107735
Christina SanInocencio, Stephanie Prince, Ilakkiah Chandran, Elijah W Simon, Laura Marks

Background: CHD2-related disorders (CHD2-RDs) are ultra-rare neurodevelopmental conditions caused by pathogenic variants in the CHD2 gene, which plays a crucial role in chromatin remodeling during brain development. These disorders present with a complex phenotype that includes refractory epilepsy, intellectual disability, autism spectrum disorder, speech and motor delays, and behavioral challenges. Despite emerging clinical descriptions, limited research has captured the lived experience of affected families or organized this complexity into a patient-centered disease model.

Methods: To develop a conceptual disease model (CDM) for CHD2-RDs, we conducted a systematic literature review alongside in-depth qualitative interviews with 15 caregivers of individuals with CHD2. Thematic saturation was reached, and findings were analyzed using inductive and deductive coding. Reflexive and AI-supported analytic techniques were employed to ensure trustworthiness. Caregiver quotes were integrated to illustrate how symptoms translate into real-world impact.

Results: The resulting CDM identifies three core domains: patient symptoms, patient impacts, and caregiver impacts. Symptom domains include seizures, cognitive impairment, communication difficulties, behavioral issues, sensory sensitivities, motor delays, and other comorbidities (e.g., GI, endocrine, vision). These symptoms disrupt sleep, development, socialization, and autonomy. Caregivers reported sleep loss, mental health strain, career disruption, and social isolation. Emergent themes, such as reliance on routine, diagnostic odyssey, and fears about the future, further contextualize the burden of CHD2-RDs.

Conclusion: This is the first caregiver-informed CDM for CHD2-RDs and provides a foundational tool for future research, clinical care, and regulatory engagement. It can inform the development of meaningful outcome measures, trial readiness, and patient-centered endpoints. The model highlights the need for integrated support and underscores the critical role of caregiver insight in understanding and addressing rare neurodevelopmental disorders.

背景:CHD2相关疾病(CHD2- rd)是由CHD2基因致病性变异引起的超罕见神经发育疾病,CHD2基因在大脑发育过程中染色质重塑中起着至关重要的作用。这些疾病具有复杂的表型,包括难治性癫痫、智力残疾、自闭症谱系障碍、言语和运动迟缓以及行为挑战。尽管出现了临床描述,但有限的研究已经捕获了受影响家庭的生活经验,或者将这种复杂性组织到以患者为中心的疾病模型中。方法:为了建立CHD2- rd的概念疾病模型(CDM),我们进行了系统的文献综述,并对15名CHD2患者的护理人员进行了深入的定性访谈。达到主题饱和,并使用归纳和演绎编码对结果进行分析。采用自反性和人工智能支持的分析技术来确保可信度。护理人员的名言被整合在一起,以说明症状如何转化为现实世界的影响。结果:由此产生的CDM确定了三个核心领域:患者症状、患者影响和护理人员影响。症状领域包括癫痫发作、认知障碍、沟通困难、行为问题、感觉敏感性、运动迟缓和其他合并症(如胃肠道、内分泌、视力)。这些症状会扰乱睡眠、发育、社交和自主性。护理人员报告睡眠不足、精神健康紧张、职业中断和社会孤立。诸如依赖常规、诊断困难和对未来的恐惧等新出现的主题进一步说明了chd2 - rd的负担。结论:这是第一个护理人员知情的chd2 - rd CDM,为未来的研究、临床护理和监管参与提供了基础工具。它可以为有意义的结果测量、试验准备和以患者为中心的终点的发展提供信息。该模型强调了综合支持的必要性,并强调了护理人员洞察力在理解和解决罕见神经发育障碍方面的关键作用。
{"title":"CHD2-related disorders: A conceptual disease model informed by caregiver experience.","authors":"Christina SanInocencio, Stephanie Prince, Ilakkiah Chandran, Elijah W Simon, Laura Marks","doi":"10.1016/j.eplepsyres.2026.107735","DOIUrl":"https://doi.org/10.1016/j.eplepsyres.2026.107735","url":null,"abstract":"<p><strong>Background: </strong>CHD2-related disorders (CHD2-RDs) are ultra-rare neurodevelopmental conditions caused by pathogenic variants in the CHD2 gene, which plays a crucial role in chromatin remodeling during brain development. These disorders present with a complex phenotype that includes refractory epilepsy, intellectual disability, autism spectrum disorder, speech and motor delays, and behavioral challenges. Despite emerging clinical descriptions, limited research has captured the lived experience of affected families or organized this complexity into a patient-centered disease model.</p><p><strong>Methods: </strong>To develop a conceptual disease model (CDM) for CHD2-RDs, we conducted a systematic literature review alongside in-depth qualitative interviews with 15 caregivers of individuals with CHD2. Thematic saturation was reached, and findings were analyzed using inductive and deductive coding. Reflexive and AI-supported analytic techniques were employed to ensure trustworthiness. Caregiver quotes were integrated to illustrate how symptoms translate into real-world impact.</p><p><strong>Results: </strong>The resulting CDM identifies three core domains: patient symptoms, patient impacts, and caregiver impacts. Symptom domains include seizures, cognitive impairment, communication difficulties, behavioral issues, sensory sensitivities, motor delays, and other comorbidities (e.g., GI, endocrine, vision). These symptoms disrupt sleep, development, socialization, and autonomy. Caregivers reported sleep loss, mental health strain, career disruption, and social isolation. Emergent themes, such as reliance on routine, diagnostic odyssey, and fears about the future, further contextualize the burden of CHD2-RDs.</p><p><strong>Conclusion: </strong>This is the first caregiver-informed CDM for CHD2-RDs and provides a foundational tool for future research, clinical care, and regulatory engagement. It can inform the development of meaningful outcome measures, trial readiness, and patient-centered endpoints. The model highlights the need for integrated support and underscores the critical role of caregiver insight in understanding and addressing rare neurodevelopmental disorders.</p>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"107735"},"PeriodicalIF":2.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiseizure medication discontinuation in pediatric epilepsy: Real-world insights 儿童癫痫的抗癫痫药物停药:现实世界的见解
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-01-27 DOI: 10.1016/j.eplepsyres.2026.107742
Deniz Menderes , Salih Akbaş , Esra Serdaroğlu , Tuğba Hırfanoğlu , Ayşe Serdaroğlu , Ebru Arhan

Objective

This retrospective study aimed to precisely characterize the factors necessitating antiseizure medication (ASM) discontinuation in pediatric epilepsy patients and to delineate drug-specific adverse event patterns based on monotherapy and polytherapy regimens.

Methods

We retrospectively analyzed data from patients under 18 years of age, followed at a single Pediatric Neurology Clinic between January 2015 and September 2024. Discontinuation was defined as the cessation of a medication due to inadequate efficacy or intolerable adverse effects. Patient demographics, epilepsy classification, ASM regimen, treatment duration, and detailed reasons for discontinuation were collected for analysis.

Results

Out of 4578 pediatric epilepsy patients screened, ASM discontinuation was recorded in 169 cases (4 %). The discontinuation rate was higher in polytherapy (68/1373, 5 %) than in monotherapy (101/3205, 3 %). The most frequent compelling reasons for cessation were seizure persistence or worsening (48/169, 28 %) and psychiatric adverse effects (40/169, 24 %). Levetiracetam was overwhelmingly associated with psychiatric complaints (25/34, 74 %), while carbamazepine demonstrated a powerful correlation with the emergence of continuous spikes and waves during sleep (CSWS) like sleep-activated epileptiform EEG pattern (28/42, 67 %), leading to its withdrawal. The mean time to discontinuation was 8 ± 6 months.

Conclusion

Our real-world data confirms that persistent seizures and drug-induced psychiatric adverse effects are the dominant causes of ASM discontinuation in children. The particular correlations between levetiracetam and psychiatric issues, and carbamazepine and CSWS-like sleep-activated EEG pattern, highlight the critical necessity for highly individualized ASM selection and close clinical and electroencephalographic monitoring in pediatric practice.
目的:本回顾性研究旨在准确描述儿童癫痫患者停用抗癫痫药物(ASM)的因素,并描述基于单药和多药治疗方案的药物特异性不良事件模式。方法回顾性分析2015年1月至2024年9月在一家儿科神经病学诊所就诊的18岁以下患者的数据。停药被定义为由于疗效不足或无法忍受的不良反应而停止使用药物。收集患者人口统计、癫痫分类、ASM方案、治疗持续时间和详细的停药原因进行分析。结果在4578例儿童癫痫患者中,有169例(4 %)停药。综合治疗的停药率(68/1373,5 %)高于单药治疗(101/3205,3 %)。最常见的令人信服的戒烟原因是癫痫发作持续或恶化(48/169,28 %)和精神不良反应(40/169,24 %)。左乙拉西坦绝大多数与精神疾病相关(25/ 34,74 %),而卡马西平与睡眠期间连续尖峰和波的出现(CSWS)密切相关,如睡眠激活的癫痫样脑电图模式(28/ 42,67 %),导致其停药。平均停药时间为8 ± 6个月。结论我们的真实数据证实,持续癫痫发作和药物性精神不良反应是儿童ASM停药的主要原因。左乙拉西坦与精神问题、卡马西平与cws样睡眠激活脑电图模式之间的特殊相关性,强调了在儿科实践中高度个性化ASM选择和密切的临床和脑电图监测的关键必要性。
{"title":"Antiseizure medication discontinuation in pediatric epilepsy: Real-world insights","authors":"Deniz Menderes ,&nbsp;Salih Akbaş ,&nbsp;Esra Serdaroğlu ,&nbsp;Tuğba Hırfanoğlu ,&nbsp;Ayşe Serdaroğlu ,&nbsp;Ebru Arhan","doi":"10.1016/j.eplepsyres.2026.107742","DOIUrl":"10.1016/j.eplepsyres.2026.107742","url":null,"abstract":"<div><h3>Objective</h3><div>This retrospective study aimed to precisely characterize the factors necessitating antiseizure medication (ASM) discontinuation in pediatric epilepsy patients and to delineate drug-specific adverse event patterns based on monotherapy and polytherapy regimens.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed data from patients under 18 years of age, followed at a single Pediatric Neurology Clinic between January 2015 and September 2024. Discontinuation was defined as the cessation of a medication due to inadequate efficacy or intolerable adverse effects. Patient demographics, epilepsy classification, ASM regimen, treatment duration, and detailed reasons for discontinuation were collected for analysis.</div></div><div><h3>Results</h3><div>Out of 4578 pediatric epilepsy patients screened, ASM discontinuation was recorded in 169 cases (4 %). The discontinuation rate was higher in polytherapy (68/1373, 5 %) than in monotherapy (101/3205, 3 %). The most frequent compelling reasons for cessation were seizure persistence or worsening (48/169, 28 %) and psychiatric adverse effects (40/169, 24 %). Levetiracetam was overwhelmingly associated with psychiatric complaints (25/34, 74 %), while carbamazepine demonstrated a powerful correlation with the emergence of continuous spikes and waves during sleep (CSWS) like sleep-activated epileptiform EEG pattern (28/42, 67 %), leading to its withdrawal. The mean time to discontinuation was 8 ± 6 months.</div></div><div><h3>Conclusion</h3><div>Our real-world data confirms that persistent seizures and drug-induced psychiatric adverse effects are the dominant causes of ASM discontinuation in children. The particular correlations between levetiracetam and psychiatric issues, and carbamazepine and CSWS-like sleep-activated EEG pattern, highlight the critical necessity for highly individualized ASM selection and close clinical and electroencephalographic monitoring in pediatric practice.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"Article 107742"},"PeriodicalIF":2.0,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146075798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare resource utilization in adults with focal onset seizures before and after initiating cenobamate: A US database analysis 成人局灶性癫痫发作前后的医疗资源利用:美国数据库分析
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-01-23 DOI: 10.1016/j.eplepsyres.2026.107739
Alessandro Lovera , Elena Alvarez-Baron , Rafia Bosan , Caroline Clare Benoist , Paola Lipone , Maria Teresa Rosignoli , Alessandro Comandini , Enrica Salvatori , Hsiu-Ching Chang , Queenie Paltanwale , Efe Eworuke , John Paul Leach , Agnese Cattaneo

Background

Antiseizure medications (ASMs) are the mainstay of treatment for patients with epilepsy, though over one third remain uncontrolled after treatment with at least two ASMs. Cenobamate is an ASM indicated for the treatment of adults with focal onset seizures (FOS) in the United States. In Europe cenobamate is approved for the adjunctive treatment of FOS in adult patients with epilepsy who have not been adequately controlled despite at least 2 previous ASMs. Real-world data helps to better describe the impact of cenobamate long-term effectiveness and tolerability/safety balance. Evidence reflecting a reduction of the impact of epilepsy on the daily lives of patients would be important when assessing and eventually predicting the benefit of treatments.

Methods

A retrospective observational study was conducted using the IQVIA PharMetrics Plus database among adult patients with both a claim for cenobamate between April 1, 2020, to April 30, 2023, and a diagnosis of FOS prior to the first cenobamate dispensing date (identified in the baseline period). Demographic characteristics were captured on the index date and clinical characteristics were captured in the 6 months baseline period; treatment patterns and healthcare resource utilization (HCRU) were assessed across 3 epochs forming 3 non-mutually exclusive cohorts: Cohort A, 6 months follow-up; Cohort B, 12 months follow-up; Cohort C, 18 months follow-up. Designated treatment regimen was defined by recorded ASMs prescribed in the 90 days following cenobamate dispensing (treatment regimen evaluation window), and patients were classified as ‘monotherapy’, ‘stable polytherapy’, or ‘changing treatment regimen’.

Results

Among the 1132 patients included in Cohort A, approximately half (45.1 %) had stable polytherapy, 1.5 % had monotherapy, and 53.5 % had a changing treatment regimen following initiation of cenobamate. Similar distribution of designation was present among the 800 patients in Cohort B and 554 patients in Cohort C. A lower proportion of patients required hospitalization and emergency department visits in the 6 months after cenobamate initiation compared to the 6-month pre-index period (Cohort A: 15.4 % vs. 21.9 % and 24.9 % vs. 30.9 % respectively). Lower HCRU reduction rates (%) per patient per month were found at 6, 12 and 18 months of follow-up.

Conclusion

Epilepsy-related hospitalizations and Emergency Room visits (indicators of seizures) were reduced in adult FOS patients with epilepsy 6, 12 and 18 months after initiating cenobamate as monotherapy or stable polytherapy, leading to reduced HCRUs and epilepsy costs.
背景:抗癫痫药物(asm)是治疗癫痫患者的主要药物,尽管超过三分之一的患者在接受至少两次asm治疗后仍无法控制。在美国,Cenobamate是一种用于治疗局灶性癫痫发作(FOS)的ASM。在欧洲,cenobamate被批准作为成年癫痫患者FOS的辅助治疗,这些患者尽管有至少2次asm,但仍未得到充分控制。真实世界的数据有助于更好地描述cenobamate长期有效性和耐受性/安全性平衡的影响。在评估和最终预测治疗的益处时,反映癫痫对患者日常生活影响减少的证据将是重要的。方法:采用IQVIA PharMetrics Plus数据库对成年患者进行回顾性观察研究,这些患者在2020年4月1日至2023年4月30日期间声称使用cenobamate,并且在第一个cenobamate分配日期(在基线期确定)之前诊断为FOS。在索引日期捕获人口统计学特征,在6个月基线期间捕获临床特征;治疗模式和医疗资源利用(HCRU)在3个时期进行评估,形成3个非互斥队列:队列A,随访6个月;B组,随访12个月;队列C,随访18个月。指定的治疗方案是通过记录在cenobamate配药后90天内规定的asm(治疗方案评估窗口)来定义的,患者被分类为“单一治疗”、“稳定的多重治疗”或“改变治疗方案”。结果在纳入队列A的1132例患者中,约有一半(45.1% %)接受稳定的综合治疗,1.5% %接受单一治疗,53.5 %在开始使用cenobamate后改变了治疗方案。在队列B的800名患者和队列c的554名患者中也存在类似的指定分布。与指数前的6个月相比,在开始治疗后的6个月内,需要住院和急诊的患者比例较低(队列A: 15.4 %对21.9 %,24.9 %对30.9 %)。随访6个月、12个月和18个月时,每个患者每月HCRU降低率(%)较低。结论成人FOS癫痫患者在开始单药治疗或稳定多药治疗6、12和18个月后,癫痫相关住院和急诊室就诊(癫痫发作指标)减少,导致hcru和癫痫费用降低。
{"title":"Healthcare resource utilization in adults with focal onset seizures before and after initiating cenobamate: A US database analysis","authors":"Alessandro Lovera ,&nbsp;Elena Alvarez-Baron ,&nbsp;Rafia Bosan ,&nbsp;Caroline Clare Benoist ,&nbsp;Paola Lipone ,&nbsp;Maria Teresa Rosignoli ,&nbsp;Alessandro Comandini ,&nbsp;Enrica Salvatori ,&nbsp;Hsiu-Ching Chang ,&nbsp;Queenie Paltanwale ,&nbsp;Efe Eworuke ,&nbsp;John Paul Leach ,&nbsp;Agnese Cattaneo","doi":"10.1016/j.eplepsyres.2026.107739","DOIUrl":"10.1016/j.eplepsyres.2026.107739","url":null,"abstract":"<div><h3>Background</h3><div>Antiseizure medications (ASMs) are the mainstay of treatment for patients with epilepsy, though over one third remain uncontrolled after treatment with at least two ASMs. Cenobamate is an ASM indicated for the treatment of adults with focal onset seizures (FOS) in the United States. In Europe cenobamate is approved for the adjunctive treatment of FOS in adult patients with epilepsy who have not been adequately controlled despite at least 2 previous ASMs. Real-world data helps to better describe the impact of cenobamate long-term effectiveness and tolerability/safety balance. Evidence reflecting a reduction of the impact of epilepsy on the daily lives of patients would be important when assessing and eventually predicting the benefit of treatments.</div></div><div><h3>Methods</h3><div>A retrospective observational study was conducted using the IQVIA PharMetrics Plus database among adult patients with both a claim for cenobamate between April 1, 2020, to April 30, 2023, and a diagnosis of FOS prior to the first cenobamate dispensing date (identified in the baseline period). Demographic characteristics were captured on the index date and clinical characteristics were captured in the 6 months baseline period; treatment patterns and healthcare resource utilization (HCRU) were assessed across 3 epochs forming 3 non-mutually exclusive cohorts: Cohort A, 6 months follow-up; Cohort B, 12 months follow-up; Cohort C, 18 months follow-up. Designated treatment regimen was defined by recorded ASMs prescribed in the 90 days following cenobamate dispensing (treatment regimen evaluation window), and patients were classified as ‘monotherapy’, ‘stable polytherapy’, or ‘changing treatment regimen’.</div></div><div><h3>Results</h3><div>Among the 1132 patients included in Cohort A, approximately half (45.1 %) had stable polytherapy, 1.5 % had monotherapy, and 53.5 % had a changing treatment regimen following initiation of cenobamate. Similar distribution of designation was present among the 800 patients in Cohort B and 554 patients in Cohort C. A lower proportion of patients required hospitalization and emergency department visits in the 6 months after cenobamate initiation compared to the 6-month pre-index period (Cohort A: 15.4 % vs. 21.9 % and 24.9 % vs. 30.9 % respectively). Lower HCRU reduction rates (%) per patient per month were found at 6, 12 and 18 months of follow-up.</div></div><div><h3>Conclusion</h3><div>Epilepsy-related hospitalizations and Emergency Room visits (indicators of seizures) were reduced in adult FOS patients with epilepsy 6, 12 and 18 months after initiating cenobamate as monotherapy or stable polytherapy, leading to reduced HCRUs and epilepsy costs.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"221 ","pages":"Article 107739"},"PeriodicalIF":2.0,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146026045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing pediatric epilepsy outcomes: Predictive variables and adherence to clinical practice guidelines 影响儿童癫痫结局的因素:预测变量和对临床实践指南的遵守
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-01-16 DOI: 10.1016/j.eplepsyres.2026.107738
Vaibhav R. Suryawanshi , Kavita Srivastava , Anshu Priya , Bhakti Sarangi , Asavari Raut

Background

Pediatric epilepsy constitutes significant challenges for long-term management in resource-limited settings. This study determined factors influencing epilepsy outcomes in children (predictive variables) and assessed adherence to clinical practice guidelines (CPG) and its effect on clinical outcomes, addressing the evidence gap in Indian settings.

Methods

We enrolled prospectively followed 170 children (<18 years) diagnosed with epilepsy, treated and monitored at a tertiary-care university hospital from ‘January 2021 to December 2024’. Adherence to clinical practice guidelines (CPG) was assessed using ‘Indian Academy of Pediatrics’ and ‘American Epilepsy Society’ standards. Clinical outcomes were studied and classified as ‘favorable (seizure freedom)’ and ‘unfavorable (seizure recurrence at 6 months of ASM initiation AND/OR active epilepsy ≥1 year of ASM initiation AND/OR time to seizure freedom exceeding 15 months after ASM initiation)’. Factors predictive of unfavorable epilepsy outcomes were analyzed using multivariate regression, and the event probabilities were estimated using Kaplan–Meier analysis.

Results

Of 170 children, 117 (68.8 %) diagnosed with new‑onset epilepsy (NOE) and 53 (31.2 %) with drug‑resistant epilepsy (DRE). The median (IQR) age was 4.6 (3.1 – 11.5) years. Male preponderance was observed [93 (54.7 %)]. Overall adherence to CPG was 70 %, with deviations noted in 28.2 % of NOE cases and in 34 % of DRE cases. Seizure recurrence at 6 months of ASM initiation [82.4 % versus 64.7 %, P = 0.034] and active epilepsy for ≥ 1 year of ASM initiation [60.8 % versus 32.8 %, P = 0.001] was higher in CPG non-adherent group. Seizure freedom was observed in a total of 100 (58.8 %) children. Patients from CPG non-adherent group took longer (>15 months) to gain seizure freedom (P < 0.042). Of 11 studied factors predictive of unfavorable epilepsy outcomes, 2 factors in NOE and 5 factors in DRE achieved statistical significance. Kaplan-Meier analysis demonstrated increased hazards of unfavorable epilepsy outcomes in patients with DRE compared to NOE, (HR 2.3, 95 % CI 1.2–4.7, P = 0.0147).

Conclusion

Adherence to CPG was associated with favorable epilepsy outcomes, while non‑adherence predicted higher risk of seizure recurrence and prolonged active epilepsy. DRE cases demonstrated significantly greater risk of unfavorable epilepsy outcomes compared to NOE, underscoring the importance of guideline‑based management in optimizing pediatric epilepsy care.
背景:在资源有限的环境下,儿童癫痫对长期管理构成重大挑战。本研究确定了影响儿童癫痫结局的因素(预测变量),并评估了临床实践指南(CPG)的遵守情况及其对临床结局的影响,解决了印度环境中的证据差距。方法从2021年1月至2024年12月,我们前瞻性随访了170名被诊断为癫痫的儿童(18岁),并在一家三级大学医院接受治疗和监测。使用“印度儿科学会”和“美国癫痫学会”的标准对临床实践指南(CPG)的依从性进行了评估。研究临床结果并将其分为“有利(癫痫发作自由)”和“不利(ASM开始6个月时癫痫发作复发和/或活动性癫痫≥1年ASM开始和/或发作自由时间超过15个月)”。采用多元回归分析预测癫痫不良结局的因素,并采用Kaplan-Meier分析估计事件概率。结果170例患儿中,117例(68.8% %)诊断为新发癫痫(NOE), 53例(31.2% %)诊断为耐药癫痫(DRE)。中位(IQR)年龄为4.6(3.1 - 11.5)岁。男性优势[93例(54.7% %)]。CPG的总体依从性为70 %,NOE病例的偏差为28.2% %,DRE病例的偏差为34% %。癫痫复发在6个月的ASM起始[82.4  % %和64.7,P = 0.034]和活动性癫痫≥1年 ASM的起始(60.8 %和32.8 % P = 0.001]在CPG non-adherent组高。100例(58.8 %)患儿癫痫发作自由。CPG非依从组患者获得癫痫发作自由所需时间较长(>;15个月)(P <; 0.042)。在研究的11个预测癫痫不良结局的因素中,NOE的2个因素和DRE的5个因素具有统计学意义。Kaplan-Meier分析显示,与NOE患者相比,DRE患者不良癫痫结局的风险增加(HR 2.3, 95 % CI 1.2-4.7, P = 0.0147)。结论坚持CPG与癫痫预后良好相关,而不坚持CPG则预示着癫痫复发和活动性癫痫延长的风险增加。与NOE相比,DRE病例表现出更大的不良癫痫结局风险,强调了基于指南的管理在优化儿科癫痫护理中的重要性。
{"title":"Factors influencing pediatric epilepsy outcomes: Predictive variables and adherence to clinical practice guidelines","authors":"Vaibhav R. Suryawanshi ,&nbsp;Kavita Srivastava ,&nbsp;Anshu Priya ,&nbsp;Bhakti Sarangi ,&nbsp;Asavari Raut","doi":"10.1016/j.eplepsyres.2026.107738","DOIUrl":"10.1016/j.eplepsyres.2026.107738","url":null,"abstract":"<div><h3>Background</h3><div>Pediatric epilepsy constitutes significant challenges for long-term management in resource-limited settings. This study determined factors influencing epilepsy outcomes in children (predictive variables) and assessed adherence to clinical practice guidelines (CPG) and its effect on clinical outcomes, addressing the evidence gap in Indian settings.</div></div><div><h3>Methods</h3><div>We enrolled prospectively followed 170 children (&lt;18 years) diagnosed with epilepsy, treated and monitored at a tertiary-care university hospital from ‘January 2021 to December 2024’. Adherence to clinical practice guidelines (CPG) was assessed using ‘Indian Academy of Pediatrics’ and ‘American Epilepsy Society’ standards. Clinical outcomes were studied and classified as ‘favorable (seizure freedom)’ and ‘unfavorable (seizure recurrence at 6 months of ASM initiation AND/OR active epilepsy ≥1 year of ASM initiation AND/OR time to seizure freedom exceeding 15 months after ASM initiation)’. Factors predictive of unfavorable epilepsy outcomes were analyzed using multivariate regression, and the event probabilities were estimated using Kaplan–Meier analysis.</div></div><div><h3>Results</h3><div>Of 170 children, 117 (68.8 %) diagnosed with new‑onset epilepsy (NOE) and 53 (31.2 %) with drug‑resistant epilepsy (DRE). The median (IQR) age was 4.6 (3.1 – 11.5) years. Male preponderance was observed [93 (54.7 %)]. Overall adherence to CPG was 70 %, with deviations noted in 28.2 % of NOE cases and in 34 % of DRE cases. Seizure recurrence at 6 months of ASM initiation [82.4 % versus 64.7 %, P = 0.034] and active epilepsy for ≥ 1 year of ASM initiation [60.8 % versus 32.8 %, P = 0.001] was higher in CPG non-adherent group. Seizure freedom was observed in a total of 100 (58.8 %) children. Patients from CPG non-adherent group took longer (&gt;15 months) to gain seizure freedom (P &lt; 0.042). Of 11 studied factors predictive of unfavorable epilepsy outcomes, 2 factors in NOE and 5 factors in DRE achieved statistical significance. Kaplan-Meier analysis demonstrated increased hazards of unfavorable epilepsy outcomes in patients with DRE compared to NOE, (HR 2.3, 95 % CI 1.2–4.7, P = 0.0147).</div></div><div><h3>Conclusion</h3><div>Adherence to CPG was associated with favorable epilepsy outcomes, while non‑adherence predicted higher risk of seizure recurrence and prolonged active epilepsy. DRE cases demonstrated significantly greater risk of unfavorable epilepsy outcomes compared to NOE, underscoring the importance of guideline‑based management in optimizing pediatric epilepsy care.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"220 ","pages":"Article 107738"},"PeriodicalIF":2.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145972764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitalisation burden among persons with epilepsy attending an outpatient neuroscience specialist clinic in Singapore 新加坡一家门诊神经科学专科诊所癫痫患者的住院负担
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2026-01-16 DOI: 10.1016/j.eplepsyres.2026.107736
Anushika Raheja , Zhibin Tan , Kaavya Narasimhalu

Background

Epilepsy carries significant clinical and socioeconomic burden, largely driven by hospitalisations. Although hospitalisation rates are well described internationally, data from Asia remain limited. We aimed to quantify hospitalisation rates among persons with epilepsy (PwE) attending an outpatient neuroscience specialist clinic in Singapore and assess whether anti-seizure medication (ASM) polytherapy is associated with hospitalisation.

Methods

This exploratory secondary analysis included PwE enrolled in a prospective cohort at a tertiary adult neurology clinic in Singapore from August 2020 to December 2022, and followed up to mid-July 2025. Polytherapy was defined as concurrent use of ≥ 2 ASMs. Incidence rate ratios (IRRs) were calculated and multivariate logistic regression identified factors associated with hospitalisation.

Results

A total of 54 PwE were followed up at the outpatient neuroscience specialist clinic for a median of 3.5 years (range 2.6–4.6). The incidence rates of all-cause hospitalisations and seizure-related hospitalisations was 0.679 hospitalisations per person-year (95 % CI: 0.401 – 1.150) and 0.189 hospitalisations per person-year (95 % CI: 0.071 – 0.501), respectively. PwE on polytherapy had significantly higher incidence rates of all-cause (incidence rate ratio, IRR 3.45, 95 % CI 1.24 – 9.90, p = 0.021) and epilepsy-related hospitalisation (IRR 7.59, 95 % CI 1.76 – 32.7, p = 0.007). On multivariate analysis, PwE on polytherapy had a higher risk of at least one all-cause hospitalisation (OR = 5.952, 95 % CI 1.504 – 23.553, p = 0.011) during the study period.

Conclusion

We report hospitalisation incidence in PwE in Singapore for the first time and describe our finding that ASM polytherapy is associated with all-cause hospitalisations. These findings may help plan further studies on the morbidity of epilepsy and how it may be better addressed.
背景:癫痫在很大程度上是由住院造成的,具有重大的临床和社会经济负担。虽然国际上对住院率的描述很好,但亚洲的数据仍然有限。我们的目的是量化在新加坡一家门诊神经科学专科诊所就诊的癫痫患者(PwE)的住院率,并评估抗癫痫药物(ASM)综合治疗是否与住院有关。方法探索性二次分析纳入了2020年8月至2022年12月在新加坡一家三级成人神经病学诊所进行的前瞻性队列研究,并随访至2025年7月中旬。多重治疗定义为同时使用≥ 2个asm。计算发病率比(IRRs),并进行多变量logistic回归,确定与住院相关的因素。结果54例PwE在神经科学专科门诊接受随访,随访时间中位数为3.5年(范围2.6 ~ 4.6年)。全因住院和癫痫相关住院的发生率分别为每人年0.679次(95 % CI: 0.401 - 1.150)和每人年0.189次(95 % CI: 0.071 - 0.501)。综合治疗组PwE的全因发生率(发病率比,IRR 3.45, 95 % CI 1.24 - 9.90, p = 0.021)和癫痫相关住院率(IRR 7.59, 95 % CI 1.76 - 32.7, p = 0.007)显著高于综合治疗组。多因素分析显示,在研究期间,综合治疗的PwE至少有一次全因住院的风险更高(OR = 5.952,95 % CI 1.504 - 23.553, p = 0.011)。结论我们首次报道了新加坡PwE的住院发生率,并描述了我们的发现,即ASM综合治疗与全因住院有关。这些发现可能有助于规划关于癫痫发病率的进一步研究以及如何更好地解决这一问题。
{"title":"Hospitalisation burden among persons with epilepsy attending an outpatient neuroscience specialist clinic in Singapore","authors":"Anushika Raheja ,&nbsp;Zhibin Tan ,&nbsp;Kaavya Narasimhalu","doi":"10.1016/j.eplepsyres.2026.107736","DOIUrl":"10.1016/j.eplepsyres.2026.107736","url":null,"abstract":"<div><h3>Background</h3><div>Epilepsy carries significant clinical and socioeconomic burden, largely driven by hospitalisations. Although hospitalisation rates are well described internationally, data from Asia remain limited. We aimed to quantify hospitalisation rates among persons with epilepsy (PwE) attending an outpatient neuroscience specialist clinic in Singapore and assess whether anti-seizure medication (ASM) polytherapy is associated with hospitalisation.</div></div><div><h3>Methods</h3><div>This exploratory secondary analysis included PwE enrolled in a prospective cohort at a tertiary adult neurology clinic in Singapore from August 2020 to December 2022, and followed up to mid-July 2025. Polytherapy was defined as concurrent use of ≥ 2 ASMs. Incidence rate ratios (IRRs) were calculated and multivariate logistic regression identified factors associated with hospitalisation.</div></div><div><h3>Results</h3><div>A total of 54 PwE were followed up at the outpatient neuroscience specialist clinic for a median of 3.5 years (range 2.6–4.6). The incidence rates of all-cause hospitalisations and seizure-related hospitalisations was 0.679 hospitalisations per person-year (95 % CI: 0.401 – 1.150) and 0.189 hospitalisations per person-year (95 % CI: 0.071 – 0.501), respectively. PwE on polytherapy had significantly higher incidence rates of all-cause (incidence rate ratio, IRR 3.45, 95 % CI 1.24 – 9.90, <em>p</em> = 0.021) and epilepsy-related hospitalisation (IRR 7.59, 95 % CI 1.76 – 32.7, <em>p</em> = 0.007). On multivariate analysis, PwE on polytherapy had a higher risk of at least one all-cause hospitalisation (OR = 5.952, 95 % CI 1.504 – 23.553, <em>p</em> = 0.011) during the study period.</div></div><div><h3>Conclusion</h3><div>We report hospitalisation incidence in PwE in Singapore for the first time and describe our finding that ASM polytherapy is associated with all-cause hospitalisations. These findings may help plan further studies on the morbidity of epilepsy and how it may be better addressed.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"220 ","pages":"Article 107736"},"PeriodicalIF":2.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145972841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epilepsy Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1